688192

Dizal (Jiangsu) Pharmaceutical
688192

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥27.47B
EV
CN¥28.01B
Shares Outstanding
459.41M
Beta
0.23

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN¥71.95
P/E 2025E
-
P/Revenue 2025E
34.47x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Dizal (Jiangsu) Pharmaceutical Co., Ltd.

gainify
688192

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

688192

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases. It develops JAUKPO, which is in Phase II clinical trials for the treatment of hematological malignancy and immunological disea...

Sector

Industry

CEO

Xiaolin, Zhang

Employees

852

IPO Date

Headquarters

199 Liangjing Rd, Zhangjiang Hi-Tech Park, Pudong District, Shanghai 201203, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.